Cayman’s p53 Transcription Factor Assay is a non-radioactive, sensitive method for detecting specific transcription factor DNA binding activity in nuclear extracts.
A specific double stranded DNA sequence containing the p53 response element is immobilised onto the wells of a 96-well plate. A nuclear extract containing p53 binds specifically to the p53 response element and is detected by addition of a specific primary antibody.
A secondary antibody conjugated to HRP is added to provide a sensitive colorimetric readout at 450 nm.
Phone: 02 9698 2022
Lonza TheraPEAK AmpliCell Cytokines and TheraPEAK 293-GT Medium
The products provide researchers and manufacturers with high-performance, scalable and...
Grace Bio-Labs protein microarray tools
Grace Bio-Labs' microarray substrates provide high binding capacity and enable high assay...
Siemens Healthineers 3gAllergy assay
Siemens Healthineers has expanded its 3gAllergy assay menu with nine additional component...